Professor Glenda Gray almost single-handedly secured 500 000 doses of the Johnson & Johnson Covid-19 vaccine for South African healthcare workers. A fearless advocate for doing what is right above all else, Gray explains why she stands on principle.
An open label, pragmatic, real world Phase 3b clinical trial of the investigational single-dose Janssen COVID-19 vaccine candidate among frontline healthcare workers in South Africa